Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline

Nadia Fairbairn; Josey Ross; Michael Trew; Karine Meador; Jeff Turnbull; Scott MacDonald; Eugenia Oviedo-Joekes; Bernard Le Foll; Marie-Ève Goyer; Michel Perreault; Christy Sutherland

doi:10.1503/cmaj.190344

Guideline

Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline

Nadia Fairbairn, Josey Ross, Michael Trew, Karine Meador, Jeff Turnbull, Scott MacDonald, Eugenia Oviedo-Joekes, Bernard Le Foll, Marie-Ève Goyer, Michel Perreault and Christy Sutherland

CMAJ September 23, 2019 191 (38) E1049-E1056; DOI: https://doi.org/10.1503/cmaj.190344

Nadia Fairbairn

Department of Medicine (Fairbairn, Sutherland), University of British Columbia; British Columbia Centre on Substance Use (Fairbairn, Ross, Sutherland), Vancouver, BC; Department of Psychiatry, Faculty of Medicine (Trew), University of Calgary; Alberta Health Services (Trew), Calgary, Alta.; Inner City Health and Wellness Program and Addiction Recovery and Community Health (Meador), Royal Alexandra Hospital, Edmonton, Alta.; Ottawa Inner City Health (Turnbull), Ottawa, Ont.; Providence Crosstown Clinic (MacDonald); School of Population and Public Health (Oviedo-Joekes), University of British Columbia; Centre for Health Evaluation & Outcome Sciences (Oviedo-Joekes), Providence Health Care, Vancouver, BC; Translational Addiction Research Laboratory (Le Foll), Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health; Departments of Family and Community Medicine, Pharmacology and Toxicology, Psychiatry (Le Foll), Institute of Medical Science, University of Toronto, Toronto, Ont.; Département de médicine de famille et de médicine d’urgence (Goyer), Faculté de médicine, Université de Montréal; Centre de recherche et d’aide pour narcomanes (Goyer), Centre intégré universitaire de santé et de services sociaux du Centre-Sudde-I’Île-de-Montréal; Department of Psychiatry (Perreault), McGill University; Douglas Mental Health Institute (Perreault), Montréal, Que.; PHS Community Services Society (Sutherland), Vancouver, BC

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Josey Ross

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Trew

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Karine Meador

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeff Turnbull

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Scott MacDonald

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eugenia Oviedo-Joekes

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bernard Le Foll

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marie-Ève Goyer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michel Perreault

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christy Sutherland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Tables
Related Content
Responses
Metrics
PDF

Data supplements

Online appendices

Files in this Data Supplement:

Appendix 1: Injectable Opioid Agonist Treatment for Opioid Use Disorder
Appendix 2: Supplemental Information - Guideline Development Methodology
Podcast
Earn CPD Credits

This article is eligible for 0.5 Mainpro+ credits.

Did you read this article?

More information

Note: The YES link above may not work in certain versions of Internet Explorer 8. If you are having difficulties with this link, please try another browser.

Scopus
PubMed
Google Scholar

PreviousNext

In this issue

Canadian Medical Association Journal: 191 (38)

CMAJ

Vol. 191, Issue 38

23 Sep 2019

Table of Contents
Index by author

Article extras

Full Guideline

Podcast

Subscribe to podcast

Download MP3

Article tools

Respond to this article

Download PDF

Article Alerts

User Name *

Password *

To sign up for email alerts or to access your current email alerts, enter your email address below:

Email *

Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline

Message Subject (Your Name) has sent you a message from CMAJ

Message Body (Your Name) thought you would like to see the CMAJ web site.

Your Personal Message

Citation Tools

Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline

Nadia Fairbairn, Josey Ross, Michael Trew, Karine Meador, Jeff Turnbull, Scott MacDonald, Eugenia Oviedo-Joekes, Bernard Le Foll, Marie-Ève Goyer, Michel Perreault, Christy Sutherland

CMAJ Sep 2019, 191 (38) E1049-E1056; DOI: 10.1503/cmaj.190344

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Request Permissions

Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline

Nadia Fairbairn, Josey Ross, Michael Trew, Karine Meador, Jeff Turnbull, Scott MacDonald, Eugenia Oviedo-Joekes, Bernard Le Foll, Marie-Ève Goyer, Michel Perreault, Christy Sutherland

CMAJ Sep 2019, 191 (38) E1049-E1056; DOI: 10.1503/cmaj.190344

Share This Article: